Seiji Okada Selected Research

Indicators and Reagents (Reagents)

4/2023	Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia/Lymphoma.
11/2022	Low serum albumin concentration is associated with increased risk of osteoporosis in postmenopausal patients with rheumatoid arthritis.
8/2015	PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Okada Research Topics

Disease

87	Neoplasms (Cancer) 05/2024 - 09/2002
32	Cholangiocarcinoma 07/2023 - 06/2010
30	Infections 10/2023 - 09/2009
28	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 01/2004
20	Primary Effusion Lymphoma 10/2022 - 09/2009
14	Rheumatoid Arthritis 01/2024 - 12/2018
13	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2012
11	Inflammation (Inflammations) 03/2024 - 07/2002
10	Lymphoma (Lymphomas) 03/2023 - 09/2009
10	Acquired Immunodeficiency Syndrome (AIDS) 10/2016 - 04/2005
9	Congenital Abnormalities (Deformity) 02/2024 - 10/2021
9	Carcinogenesis 12/2023 - 05/2007
8	Pain (Aches) 03/2024 - 04/2012
8	Wounds and Injuries (Trauma) 10/2023 - 04/2008
8	Cicatrix (Scar) 01/2023 - 12/2005
7	Osteoporosis 02/2024 - 10/2021
6	Gliosis 01/2023 - 06/2005
5	Melanoma (Melanoma, Malignant) 01/2018 - 08/2013
5	Ascites 06/2017 - 09/2009
4	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 01/2017
4	Spinal Cord Diseases 12/2023 - 04/2012
4	Hypoxia (Hypoxemia) 01/2023 - 01/2016
4	Fibrosis (Cirrhosis) 01/2023 - 01/2017
4	Leukemia 03/2021 - 08/2007
4	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 03/2012
3	Multiple Myeloma 03/2024 - 05/2022
3	Postmenopausal Osteoporosis 01/2024 - 10/2021
3	Osteoarthritis 01/2024 - 01/2022
3	Hematoma 01/2024 - 03/2013
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 03/2010
3	Hallux Valgus 08/2023 - 10/2021
3	Hyperglycemia 07/2023 - 10/2014
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 04/2023 - 11/2007
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 01/2016
3	Necrosis 01/2023 - 03/2007
3	Squamous Cell Carcinoma of Head and Neck 12/2022 - 02/2015
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2013
3	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 01/2012
3	HIV Infections (HIV Infection) 09/2018 - 09/2016
3	Disease Progression 01/2018 - 04/2005
3	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2014
2	Spinal Injuries (Spinal Injury) 03/2024 - 01/2023

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2002
15	CytokinesIBA 12/2023 - 07/2002
8	Therapeutic UsesIBA 01/2024 - 08/2007
7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 03/2004
7	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023 - 07/2012
5	cepharanthineIBA 01/2023 - 09/2009
5	CollagenIBA 01/2023 - 11/2011
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2005
5	Antineoplastic Agents (Antineoplastics)IBA 05/2019 - 08/2013
5	Liposomes (Liposome)IBA 12/2017 - 03/2010
5	NF-kappa B (NF-kB)IBA 01/2014 - 11/2007
4	CyclodextrinsIBA 11/2023 - 10/2014
4	Folic Acid (Vitamin M)FDA LinkGeneric 11/2023 - 03/2014
4	Messenger RNA (mRNA)IBA 01/2023 - 07/2012
4	Small Interfering RNA (siRNA)IBA 11/2020 - 07/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2016 - 03/2013
4	src-Family KinasesIBA 03/2012 - 04/2005
3	C-Reactive ProteinIBA 03/2024 - 05/2022
3	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2019
3	romosozumabIBA 01/2024 - 10/2021
3	AntigensIBA 01/2024 - 01/2018
3	Peptides (Polypeptides)IBA 11/2023 - 01/2018
3	Janus Kinase InhibitorsIBA 07/2023 - 01/2022
3	Indicators and Reagents (Reagents)IBA 04/2023 - 08/2015
3	VaccinesIBA 01/2023 - 09/2002
3	ZincIBA 01/2023 - 03/2019
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2023 - 06/2005
3	PeriostinIBA 01/2023 - 03/2017
3	Cadherins (E-Cadherin)IBA 01/2023 - 01/2014
3	IntegrinsIBA 01/2023 - 07/2017
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2013
3	Monoclonal AntibodiesIBA 10/2022 - 06/2021
3	BerberineIBA 10/2022 - 04/2012
3	Gemcitabine FDA Link 01/2022 - 01/2021
3	AcidsIBA 07/2021 - 03/2020
3	Histones (Histone)IBA 01/2021 - 01/2017
3	Nuclear Proteins (Protein, Nuclear)IBA 10/2020 - 07/2012
3	Janus Kinase 3IBA 01/2019 - 09/2009
3	VimentinIBA 05/2018 - 01/2012
3	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2017 - 09/2013
2	MidkineIBA 03/2024 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 06/2021

Therapy/Procedure

33	Therapeutics 01/2024 - 04/2002
14	Transplantation 01/2023 - 01/2004
13	Drug Therapy (Chemotherapy) 08/2023 - 01/2010
8	Osteotomy 01/2024 - 09/2013
7	Activities of Daily Living (ADL) 03/2024 - 12/2017
7	Immunotherapy 01/2024 - 08/2015
5	Arthroplasty 03/2024 - 01/2022
4	Heavy Ion Radiotherapy 04/2023 - 01/2017
4	Decompression 11/2016 - 04/2012
3	Operative Surgical Procedures 12/2023 - 10/2021
3	Cell Transplantation 12/2023 - 01/2004
3	Intraperitoneal Injections 11/2023 - 09/2009
3	Radiotherapy 12/2022 - 01/2017
3	Highly Active Antiretroviral Therapy (HAART) 08/2019 - 03/2010